CSI Market
Sign In | Register

Mural Oncology Plc (MURA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MURA Annual Cash Flow →
Examining cash flow movements between Mural Oncology Plc and Sep 30 2024 reveals how Sep 30 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
9 Months 		(Jun 30 2025) (Mar 31 2025) (Dec 31 2024) (Sep 30 2024)
Operating Activities
Income-84.83
Depreciation & amortization2.79
Amortization of Other Assets0.00
Impairment of assets0.00
Impairment of Long-Lived Assets to be Disposed of3.25
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Derivatives0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation-0.50
Undistributed earnings from affiliate0.00
Tax benefit on stock options0.00
Increase Decrease In Right Of Use Assets3.65
Impairment Of Long Lived Assets-
Increase Decrease In Operating Lease Liability-4.48
Increase Decrease In Receivable From Former Parent0.05
Income taxes0.00
Accrued expenses0.00
Accounts receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-13.80
Investing losses/ -gains net0.00
Unrealized loss/ -gain0.00
Increase (Decrease) in Prepaid Expense3.92
Other Working Capital0.90
Employee benefit plans0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities2.41
Discontinued operations0.00
Net Cash flow from Operating Activities-86.64
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.78
Proceeds from Sale and Maturity of Marketable Securities29.00
Payments to Acquire Marketable Securities0.00
Proceeds from other investments0.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Purchases of Investments0.00
Purchases of non-current assets0.00
Acquisition net of cash acquired0.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Other0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities29.77
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock0.03
Proceeds from Contributions from Parent0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net0.00
Other net-117.43
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents117.43
Capital Expenditures Incurred But Not Yet Paid-
Dividends paid to minority interests0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.03
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-85.88
Total Cash Flow-56.85
4 historic quarters locked

Sign in to unlock the full Mural Oncology Plc cash flow history.

Sign In Create Free Account

About Mural Oncology Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-25-268122

Figures are derived from filed reports and may be restated. Historical data is subject to revision.